Posts Tagged ‘High Dose Vitamin C’

Cancer Deception

In Alternative Cancer Therapies, Alternatives Cancer Treatment, Anticancer foods, foods for colon cancer, foods for breast cancer, Breast Cancer, Cancer, cancer stem cells and recurrence, chemo and cancer stem cells, Healing Cancer Naturally, High Dose Vitamin C, targeting cancer stem cells on June 12, 2017 at 7:09 pm

By Elyn Jacobs and Dr. Michael Schachter

This article was originally written for and posted on  BeatCancer.org.

“Alternative treatment protocols have the potential to be competitive if not superior to conventional treatments. They should be considered as primary, not merely supplementary options for treatment.”  — Dr. Michael B. Schachter

If you don’t know your options, you don’t have any.”    —Elyn Jacobs, Cancer Coach

cancer deception

This past June, Dr. Michael Schachter presented at the 2016 International Conference: The Latest Developments in Integrative Cancer Therapies, held in Melbourne and Sydney, Australia. (He has been lecturing on this topic for years, throughout the United States and elsewhere.)

A major thesis of his presentation was that alternative treatment protocols have the potential to be competitive if not superior to conventional treatments. They should be considered as primary– not merely supplementary options for treatment.

Losing the Cancer War

Dr. Schachter stated we are losing the “war on cancer” as declared by President Nixon in the early 1970’s, with little improvement in the death rate and higher incidence of many cancers. The reason for this is that the cancer effort was really misfocused from the start. One problem is that there has been an emphasis on trying to cure cancer rather than on preventing it. Another problem is that treatment emphasized patent-able toxic drugs and radiation without paying sufficient attention to relatively non-toxic natural approaches like low dose Naltrexone,  IV Vitamin C, Salvestrols and others. Clearly, preventive strategies have worked for reducing the incidence and mortality of heart disease and stroke, but the medical establishment has put up severe resistance to the idea that we can best manage cancer by preventing it.

In fact, Dr. Schachter was quick to point out that despite the billions of dollars spent, there has been virtually no change in the death rates from cancer from 1950 to date. This is in stark contrast to the approximately 70% reduction in deaths from other conditions such as heart disease and stroke.

The Five-Year Survival Yardstick

Certainly, the five-year survival rate for cancer has increased, but that number is misleading—it provides no clue as to how many survivors are free of their disease. Included in this number are hundreds of thousands of people who will battle cancer to the five-year mark and beyond, only to have endured one toxic protocol after another. [Editor’s note: and frequently poor quality of life. Surviving is not the same as thriving!]

Furthermore, because diagnostic tests are finding more cancers at an early stage, more patients are being treated at an early stage. This translates to more patients making this five-year mark. However, this is at a stiff cost—for example, in the case of breast cancer, earlier benchmarking means more harmful testing and many unnecessary biopsies when something suspicious comes up on a mammogram. But a significant number of these early stage patients will be re-diagnosed as “late stage” six to ten years from their first diagnosis. And a patient who dies after a grueling six-year battle with cancer is nevertheless placed in the “survived” category because she has survived more than five years from the time of diagnosis. So you see, not only is the current standard of care not working, but the methodology of collecting statistics is flawed.

And although more patients are living longer today, only a small portion of that longevity has come from advances in conventional cancer treatment. Despite the endless procession of “wonder drugs,” the deadliest of cancers are still as deadly now as they were at the start of “the war.” 

Limits of Drug Therapy

What the failure of the “war on cancer” implies is that pretty much every agent in the fight against cancer—those myriad compounds that have set the research community abuzz and which have generated billions of dollars in profits — have had only a modest effect on long-term patient outcomes.

The latest progress in anti-cancer drugs seems to be with targeted therapies. This approach uses patented medications to inhibit or block biochemical pathways that play a role in cancer growth and spread. Most generics of these medications end in “mab” (monoclonal antibodies) or “nib” (small molecules). Examples are: Herceptin = Trastuzumab and Avastin = Bevacizumab (monoclonal antibodies) and Gleevec = Imatinib and Tarceva = Erlotinib (small molecules). The problem is that because there are many pathways within a cancer, these drugs have only limited effectiveness, and they also have undesirable side effects. Furthermore, since these pathways are used for normal cell functions as well, strong inhibition of a cancer pathway may cause severe complications in healthy cells. Moreover, many of these cancer pathways can be blocked with natural substances with much fewer side effects.

The cancer industry wants you to believe that its drugs are useful, and oncologists are joyful when a patient’s tumor shrinks on drug treatment. The problem is that shrinking tumors has little to do with improving the long-term survival of patients. It is not the initial tumor that kills people but rather the metastasis of the cancer cells. Aggressive cells break off from the primary tumor site and travel to the bones, brain, liver, lungs, or to some other vital area of the body. Even if an entire tumor is removed, and even if the nearby lymph nodes are negative for cancer, microscopic cells often recolonize elsewhere and are not found until later. According to Dr. Schachter, metastasis is what kills. [Editor’s note: Most cancer patients do not die from their disease at all, but rather from malnutrition, toxemia, and/or infections.]

Unfortunately, cancer treatments such as chemo and radiation not target the very cells responsible for metastases — the cancer stem cells – and in fact may encourage them to grow faster. This is one of the main reasons that conventional treatments like radiation and chemotherapy produce such poor results in the treatment of stage IV metastases (cancers that have spread to distant organs). A promising approach to this problem — though generally ignored by conventional oncologists — is the use of relatively non-toxic, anti-inflammatory herbs and nutrients. Substances that target cancer stem cells like black cumin, curcumin, broccoli extracts, vitamin D, and many others can play an important role. For more on this topic, please read Cancer Stem Cells and Progression of Disease: What You Need to Know Now.

Furthermore, we now know that conventional treatments sharply raise the risk for heart problems, stroke, and secondary cancers. Children are particularly at risk. Pediatric survivors have a six-fold greater risk of getting a second cancer, and adults face significant risk for complications as well.

No great insight is required to see that that our cancer-strategy is flawed. The ultimate problem lies in the cancer culture itself.

Challenging Traditional Views of Cancer

Surprisingly, decades ago some scientists viewed the cancer mechanism differently from the vast majority of cancer theorists. In recent years, the theory of cancer as outlined by Otto Warburg in the 1920’s has become more widely accepted. According to a written statement by Dr. Warburg,

“But nobody today can say that one does not know what cancer and its prime cause [are]. On the contrary, there is no disease whose prime cause is better known, so that today ignorance is no longer an excuse that one cannot do more about prevention. That prevention of cancer will come there is no doubt, for man wishes to survive. But how long prevention will be avoided depends on how long the prophets of agnosticism will succeed in inhibiting the application of scientific knowledge in the cancer field. In the meantime, millions of men must die of cancer unnecessarily.” [i]

— Dr. Otto Warburg, Medical Nobel Prize winner, Lindau, Germany, 1966

In 1986, John Bailar, a National Cancer Institute (NCI) statistician, also had the nerve to question the progress in the war on cancer, although he was severely ridiculed and shunned for doing so. In his 1986 paper “Progress Against Cancer?” Bailar argued that cancer research focuses too much on treatment and not enough on prevention, which would be far more effective. Then in 1997 in his paper “Cancer Undefeated” he concluded that “the effect of new treatments for cancer on mortality has been largely disappointing.”[ii]

In 1996, Michael Sporn, in an article printed in The Lancet, declared the war on cancer a failure. [iii] He predicted that the NCI would not achieve its stated target of a 50% reduction in cancer deaths by the year 2000. Sadly, he was right. Sporn believed that cancer could be chemically stopped, slowed, or reversed in its earliest pre-invasive stages. He even coined the widely-used term chemoprevention to distinguish cancer intervention from treatment. His was a truly radical idea in the cancer community.

Sporn’s goal was to dislodge the theory that cancer is something that just happens suddenly, that it is even a disease state. He did not subscribe to the idea that one either has cancer or not. Oncologists treat cancer, but logically, cancer is not an event of any kind. It does not suddenly happen upon diagnosis. It comes from years of dis-ease—it is a process. It begins when normal differentiation of a cell fails, when proper communication halts, and when the environment encourages cancer development. Long before cancer is detected, cancer is brewing—through a process known as carcinogenesis. It is nonsense to believe that the process has not been under way for many years.

Time for Change

Thankfully, our understanding of the nature of cancer and cancer treatment are in the process of undergoing major changes — though for economic and social reasons, there is tremendous resistance to these changes. Resistance comes from pharmaceutical companies, organized medicine, insurance companies, institutes of medical education, and the media. But if the path to cancer is something we can understand, why not treat it that way? It would be prudent to address the smoke before the fire burns down the house—to heal the patient at the very first signs of disease.

What if we could look at risk factors and markers, use diet instead of drugs, and use targeted supplements to prevent the development and progression of cancer? What if we were to heal the person with the cancer instead of just targeting the cancer? Surely, we would then stand a greater chance of winning the war. What if treatment for cancer patients started with a focus on lifestyle and nutritional changes? Considering that in many cases poor nutritional and lifestyle choices have contributed to the development of cancer, it would seem prudent to address such issues. Rather than just focusing on toxic conventional treatments, we could use various nutrients, herbs, and other non-toxic supplements in a synergistic way to improve the results with conventional treatment or, in some cases, instead of conventional treatment.

For sure, it is time to question the cancer strategy. It’s time for change.

For More Information

To view slides and notes from Dr. Schachter’s recent lectures, visit this link: http://www.schachtercenter.com/lecture_pdfs.htm

You may also want to view these two papers by Dr. Schachter:
“Integrative Oncology for Clinicians and Cancer Patients,” accessible at http://schachtercenter.com/IntegrativeOncologyISIMJournal.pdf  

”Integrating Nutrition and Selected Controversial Nutritional Supplements into a Cancer Treatment Program,” accessible at http://schachtercenter.com/ CSJARTICLE0001.PDF

Read more on Low Dose Naltrexone HERE.

Read more on why we are losing the War Against Cancer

Read more about High Dose Vitamin C HERE.


Dr. Michael B. Schachter is a magna cum laude graduate of Columbia College and Columbia P&S Medical School in NYC. He is also a Board-Certified Psychiatrist and a Certified Nutrition Specialist. Dr. Schachter has been involved with nutritional and integrative health care for over40 years. A leader in alternative cancer therapies, EDTA chelation and orthomolecular psychiatry, he is a past president of the American College of Advancement in Medicine (ACAM). He has authored numerous articles and was a major contributor to Burton Goldberg’s 1997 classic Alternative Medicine Definitive Guide to Cancer. In 2010, Dr. Schachter received the Humanitarian Award from the Cancer Control Society in California. He is the director of the Schachter Center for Complementary Medicine in Suffern, NY.

Elyn Jacobs is a breast cancer survivor and holistic cancer strategist who helps people make better, healthier, non-toxic choices. She specializes in understanding the role of estrogen in breast cancer and emphasizes the critical nature of addressing the root cause of cancer rather than its presenting symptoms. Elyn is a Contributing Editor for The Truth About Cancer and was creator and host of the Survive and Live Well Radio Show on the Cancer Support Network. Certified as a holistic cancer educator through BeatCancer.org, she serves on its Medical Advisory Board as well as on the Advisory Board for the Radical Remission Project. Elyn was formerly Executive Director of the Emerald Heart Cancer Foundation.


[1] http://www.healthyfoodhouse.com/12-quotes-from-medical-doctors-that-the-cancer-treatment-industry-doesnt-want-you-to-read/ ; Dr Otto Warburg’s Cancer Research Papers

[2] http://www.nejm.org/doi/full/10.1056/NEJM199705293362206#t=article

[3] http://www.nejm.org/doi/full/10.1056/NEJM199705293362206#t=article; https://www.ncbi.nlm.nih.gov/pubmed/8637346



~~If you don’t know your options, you don’t have any~~

Elyn Jacobs is a breast cancer survivor and holistic cancer strategist who helps people make better, healthier, non-toxic choices. She emphasizes the critical nature of addressing the root cause of cancer and not just its presenting symptoms (such as the tumor). Elyn specializes in understanding the role of estrogen in breast cancer and debunks the myths associated. She is a Contributing Editor for The Truth About Cancer and was creator and host of the Survive and Live Well Radio Show on the Cancer Support Network. Elyn is on the Medical Advisory Board for BeatCancer.Org and is on the Advisory Board to the Radical Remission Project. Elyn was the Executive Director of the Emerald Heart Cancer Foundation. Contact Elyn via her website, www.elynjacobs.com. Elyn offers consults via Skype, phone or in person.

Follow Elyn on Facebook
Follow Elyn on LinkedIn

High Dose Vitamin C: The Other Cancer Therapy

In Alternative Cancer Therapies, Cancer, Healing Cancer Naturally, High Dose Vitamin C, High Dose Vitamin C and Cancer on September 17, 2016 at 10:17 am

Can Oral High Dose Vitamin C Kill Cancer Cells More Effectively than Intravenous C?

The use of High-Dose Vitamin C for cancer mitigation and management has been studied for years. Holistically minded professions use HDVC in conjunction with other innovative treatments to maximize effectiveness. Most of these doctors do not use traditional chemotherapy or radiation as they often cause permanent or even fatal side effects –these therapies destroy all cells, healthy and malignant, eventually leading to patient death.

Building on the work of Linus Pauling, who was recognized as the world’s foremost advocate of therapeutic vitamin C, significant research shows that high dose vitamin C (HDVC) effectively eradicates cancer cells while leaving healthy cells intact. HDVC has been used alongside cancer therapies (both conventional and holistic) since the 1970’s. While not considered to be a cancer cure, it is a powerful adjunctive therapy for cancer patients.

Ascorbic acid is preferentially toxic to tumor cells suggesting that it could be useful as a chemotherapeutic agent. While again I would not suggest using HDVC as a stand-alone treatment, studies have shown it to kill cancer cells, slow the growth of cancers, and greatly improve the effectiveness of other cancer treatments. Some research shows that HDVC can reduce tumor size and may lead to tumor regression, including in patients with metastatic disease.

 Antioxidant vs Pro-oxidant

At ordinary doses, vitamin C acts as an antioxidant, protecting cells from free radical damage. However, at high doses, it acts like a pro-oxidant drug that produces hydrogen peroxide, which targets cancer cells while leaving normal cells unharmed. Hydrogen peroxide is lethal to cancer cells. It oxidizes the tissues by converting the free radicals into hydrogen peroxide that can destroy the cancer cells and inhibit their energy supply.

According to Dr Steve Hickey, PhD, ” Fortunately within tumors, vitamin C and certain other dietary ‘antioxidants’ act as oxidants, rather than antioxidants.  Morever, the same substances act as antioxidants within healthy cells.  This means they can destroy cancer cells, while simultaneously improving the health of the rest of the body.”

According to the National Institute of Health:

“Many laboratory studies have been done to find out how high-dose vitamin C may cause the death of cancer cells. The anticancer effect of vitamin C in different types of cancer cells involves a chemical reaction that makes hydrogen peroxide, which may kill cancer cells.”

Vitamin C also does more than just kill cancer cells. It boosts immunity which we know is essential for the prevention and management of cancer.

Vitamin C, Immunity, and Cancer: 

  • Increased immune function with enhanced antibody production (lymphocytes)
  • Stimulation of collagen formation necessary to wall off tumors (replacement and destruction of tumor cells)
  • Enhanced natural killer cell activity
  • Inhibits of hyaluronidase to keep ground substance intact and preventing metastases
  • Inhibition of oncogenic viruses
  • Supports the p53 tumor suppressor gene
  • Corrections of C deficiency commonly seen in cancer patients
  • Enhanced healing of surgical wounds
  • Enhanced anticancer effects of certain chemotherapeutic agents
  • Chemotherapy and radiation better tolerated when HDVC is used (including reduced pain)
  • Combining high dose vitamin C with radiation and/or certain types of chemo may be more effective than these treatments on their own
  • Prevents free radical damage by responding to inflammation and its resulting oxidative stress
  • Produces hydrogen peroxide which may help to kill cancer cells by forming the hydroxyl radical in cancer cells because they lack catalase
  • May help to neutralize certain cancer producing substances

There is a plethora of research beyond the early studies done by Pauling and Cameron. For example, Drs. Murata and Morishige of Saga University in Japan showed that cancer patients given 5–30g of vitamin C lived six times longer than those on 4g or less, while those suffering from cancer of the uterus lived 15 times longer on vitamin C therapy. This was also confirmed by the late Dr Abram Hoffer in Canada, who found that patients on high doses of vitamin C survived, on average, ten times longer.

Treatment with high-dose vitamin C has been found to slow the growth and spread of prostate, breast, pancreatic, liver, colon, malignant mesothelioma, neuroblastoma, and other types of cancers.

Oral Vitamin C is better Than Intravenous Vitamin C

However through the work of Hickey, and others, we have learned that not only can oral intake be as effective as intravenous C, it can actually be even more effective. Hickey maintains that since you can take oral vitamin C throughout the day as well as daily, the treatment is more effective.

He says that “the ‘vitamin C as chemotherapy’ model used for IVC assumes delivery of a relatively short, high burst of ascorbate. However, this does not apply to oral doses, which can be used to produce long term, sustained plasma levels.”  His findings show a large increase in cancer toxicity when the experimental exposure time was increased from 1 hour to 24 hours. He also found that alpha alpha-lipoic acid (R-ALA), copper, selenium, and other redox (oxygen –reducing) active supplements greatly increase the selective cytotoxicity of ascorbate.”

You may find the full article informative: Vitamin C and Cancer: Is There a Use for Oral C

The trick to being able to consume high levels of oral C without the typical bowel intolerance is to use Liposomal C or  Sodium Ascorbate  My two favorite brands of liposomal C are Mercola  and  Lypo-Spheric .  You can also make it at home.  One trip to google will provide DIY methods.

Update: Vitality C  is also an excellent option for sodium ascorbate and seems to more pleasant than other products. Another option is this liquid liposomal C. You can also use some Vitamin C with Bioflavonoids & Rose Hips (great for adrenal support) as part of the regimen.

To find your best dosage, you might find test strips helpful.

The Role of Sodium Ascorbate  

While liposomal C has been used for many years, new research has found that another form of vitamin C, sodium Ascorbate, is highly effective as  is also more affordable.

Please view this extremely informative video by  Dr Suzanne Humphries.  You will learn the safety and health benefits of  high dose vitamin C. She includes considerable information as to why sodium ascorbate can be helpful in your protocol.

How to Use HDVC

It is important to work with a professional before beginning this treatment.

  • A  G6PD test is recommended before any IVC infusions are given. Patients with a rare inherited disorder called G-6-PD deficiency should not be given high doses of vitamin C, due to the risk of hemolysis (a condition in which red blood cells are destroyed). Patients with a history of kidney disorders should not be treated with HDVC unless at the advice of a qualified physician (and supplementation with B6 as well as magnesium).
  • It is best to start slowly. Practitioners typically start a patient with 10 or 20 grams, increasing over a period of time to 50 grams. In previous years the doses went as high as 100 grams, but more recent research indicates this is not necessary. For oral C, you may want to start out with small doses, starting at 1-2 grams, three times a day and build up to your optimal dose which could be anywhere from 4-20 grams.
  • The use of ascorbic acid urine strips is recommended to find the right dose you’re your individual needs.
  • Consider supportive supplements such as alpha alpha-lipoic acid (R-ALA) and selenium.
  • You may feel ‘wiped out’, foggy, or shaky when you first begin this treatment. Plan accordingly. If using IVC, be sure you have someone to escort you home. If starting at home, plan to take a restorative nap. Consuming calcium/magnesium rich foods during this therapy can help alleviate such symptoms.
  • Do not use IV Glutathione the same day as HDVC as they will cancel each other out (antioxidant and proxidant).
  • Never begin any new therapy without the advice of a qualified physician

For more information and resources:

https://www.csom.ca/wp-content/uploads/2013/03/Vitamin-C-and-Cancer-Is-There-A-Use-For-Oral-Vitamin-C-28.1.pdf  Steve Hickey, PhD and Hilary Roberts, PhD










You may also want to visit the website of the Vitamin C Foundation at: http://vitamincfoundation.org/alerts.php

~~If you don’t know your options, you don’t have any~~
Elyn Jacobs is a breast cancer survivor and holistic cancer strategist who helps people make better, healthier, non-toxic choices. She emphasizes the critical nature of addressing the root cause of cancer and not just its presenting symptoms (such as the tumor). Elyn specializes in understanding the role of estrogen in breast cancer and debunks the myths associated. She is a Contributing Editor for The Truth About Cancer and was creator and host of the Survive and Live Well Radio Show on the Cancer Support Network. Elyn is on the Medical Advisory Board for BeatCancer.Org and is on the Advisory Board to the Radical Remission Project. Elyn was the former Executive Director of the Emerald Heart Cancer Foundation. Contact Elyn via her website. Elyn offers consults via Skype, phone or in person.

Follow Elyn on Facebook

Follow Elyn on Linkedin